References
Shapiro, M. D., Tavori, H. & Fazio, S. PCSK9: from basal subject discoveries to objective trials. Circ. Res. 122, 1420–1438 (2018).
Sahin, U., Karikó, K. & Türeci, Ö. mRNA-based therapeutics—developing a caller people of drugs. Nat. Rev. Drug Discov. 13, 759–780 (2014).
Global Spending connected Health: a World successful Transition (WHO, 2019).
Global Health Estimates 2019: Life Expectancy, 2000–2019 (WHO, 2020).
Schroeder, S. A. Shattuck Lecture. We tin bash better—improving the wellness of the American people. N. Engl. J. Med. 357, 1221–1228 (2007).
Roden, D. M. et al. Pharmacogenomics. Lancet 394, 521–532 (2019).
Le, D. T. et al. PD-1 blockade successful tumors with mismatch-repair deficiency. N. Engl. J. Med. 372, 2509–2520 (2015).
Olstad, D. L. & McIntyre, L. Reconceptualising precision nationalist health. BMJ Open 9, e030279 (2019).
Middleton, P. G. et al. Elexacaftor–tezacaftor–ivacaftor for cystic fibrosis with a azygous Phe508del allele. N. Engl. J. Med. 381, 1809–1819 (2019).
Cully, M. Target validation: familial accusation adds supporting weight. Nat. Rev. Drug Discov. 14, 525 (2015).
King, E. A., Davis, J. W. & Degner, J. F. Are cause targets with familial enactment doubly arsenic apt to beryllium approved? Revised estimates of the interaction of familial enactment for cause mechanisms connected the probability of cause approval. PLoS Genet. 15, e1008489 (2019).
Ochoa D. et al. Human genetics grounds supports two-thirds of the 2021 FDA-approved drugs. Nat. Rev. Drug Discov. 21, 551 (2022).
Stark, Z. et al. Integrating genomics into healthcare: a planetary responsibility. Am. J. Hum. Genet. 104, 13–20 (2019).
The All of Us Research Program Investigators et al. The ‘All of Us’ Research Program. N. Engl. J. Med. 381, 668–676 (2019).
Turnbull, C. et al. The 100 000 Genomes Project: bringing full genome sequencing to the NHS. BMJ 361, k1687 (2018).
Stark, Z. et al. Australian genomics: a federated exemplary for integrating genomics into healthcare. Am. J. Hum. Genet. 105, 7–14 (2019).
Cohn, E. G., Henderson, G. E. & Appelbaum, P. S. Distributive justice, diversity, and inclusion successful precision medicine: what volition occurrence look like? Genet. Med. 19, 157–159 (2017).
Caffrey, M. Disparities successful crab care: has precision medicine widened the gap? AJMC (22 April 2021).
Sirugo, G., Williams, S. M. & Tishkoff, S. A. The missing diverseness successful quality familial studies. Cell 177, 26–31 (2019).
Taliun, D. et al. Sequencing of 53,831 divers genomes from the NHLBI TOPMed Program. Nature 590, 290–299 (2021).
Karczewski, K. J. et al. The mutational constraint spectrum quantified from saltation successful 141,456 humans. Nature 581, 434–443 (2020).
Manrai, A. K. et al. Genetic misdiagnoses and the imaginable for wellness disparities. N. Engl. J. Med. 375, 655–665 (2016).
Martin, A. R. et al. Clinical usage of existent polygenic hazard scores whitethorn exacerbate wellness disparities. Nat. Genet. 51, 584–591 (2019).
Martin, A. R. et al. Human demographic past impacts familial hazard prediction crossed divers populations. Am. J. Hum. Genet. 100, 635–649 (2017).
Privé, F. et al. Portability of 245 polygenic scores erstwhile derived from the UK Biobank and applied to 9 ancestry groups from the aforesaid cohort. Am. J. Hum. Genet. 109, 12–23 (2022).
Graham, S. E. et al. The powerfulness of familial diverseness successful genome-wide relation studies of lipids. Nature 600, 675–679 (2021).
Atkinson, E. G. et al. Tractor uses section ancestry to alteration the inclusion of admixed individuals successful GWAS and to boost power. Nat. Genet. 53, 195–204 (2021).
Mahajan, A. et al. Trans-ancestry familial survey of benignant 2 diabetes highlights the powerfulness of divers populations for find and translation. Nat. Genet. 54, 560–572 (2022).
Chambers, J. C. et al. Epigenome-wide relation of DNA methylation markers successful peripheral humor from Indian Asians and Europeans with incidental benignant 2 diabetes: a nested case–control study. Lancet Diabetes Endocrinol. 3, 526–534 (2015).
Chandalia, M. et al. Insulin absorption and assemblage abdominous organisation successful South Asian men compared to Caucasian men. PLoS ONE 2, e812 (2007).
Wu, D. et al. Genetic admixture successful the culturally unsocial Peranakan Chinese colonisation successful Southeast Asia. Mol. Biol. Evol. 38, 4463–4474 (2021).
Population Trends, 2021 (Singapore Department of Statistics, 2021).
Government Health Expenditure and Healthcare Financing (Singapore Ministry of Health, 2018).
GBD 2017 Disease and Injury Incidence and Prevalence Collaborators Global, regional, and nationalist incidence, prevalence, and years lived with disablement for 354 diseases and injuries for 195 countries and territories, 1990–2017: a systematic investigation for the Global Burden of Disease Study 2017. Lancet 392, 1789–1858 (2018).
Huang, K. K. et al. Genomic and epigenomic profiling of high-risk intestinal metaplasia reveals molecular determinants of progression to gastric cancer. Cancer Cell 33, 137–150 (2018).
Metspalu, A., Köhler, F., Laschinski, G., Ganten, D. & Roots, I. The Estonian Genome Project successful the discourse of European genome research. Dtsch. Med. Wochenschr. 129, S25–S28 (2004).
Chen, J. et al. Genomic scenery of lung adenocarcinoma successful East Asians. Nat. Genet. 52, 177–186 (2020).
Bylstra, Y. et al. Implementation of genomics successful aesculapian signifier to present precision medicine for an Asian population. NPJ Genom. Med. 4, 12 (2019).
McGuire, A. L. et al. The roadworthy up successful genetics and genomics. Nat. Rev. Genet. 21, 581–596 (2020).
Life Insurance Association (LIA) Moratorium connected Genetic Testing and Insurance (Singapore Ministry of Health, 2021).
Lysaght, T. et al. Trust and trade-offs successful sharing information for precision medicine: a nationalist survey of Singapore. J. Pers. Med. 11, 921 (2021).
Lysaght, T. et al. ‘Who is watching the watchdog?’: ethical perspectives of sharing health-related information for precision medicine successful Singapore. BMC Med. Ethics 21, 118 (2020).
Ong, S., Ling, J., Ballantyne, A., Lysaght, T. & Xafis, V. Perceptions of ‘precision’ and ‘personalised’ medicine successful Singapore and associated ethical issues. Asian Bioeth. Rev. 13, 179–194 (2021).
Majithia, S. et al. Cohort profile: the Singapore Epidemiology of Eye Diseases survey (SEED). Int. J. Epidemiol. 50, 41–52 (2021).
Tan, K. et al. Cohort profile: the Singapore Multi-Ethnic Cohort (MEC) study. Int. J. Epidemiol. 47, 699–699j (2018).
Soh, S. et al. Cohort profile: Growing Up successful Singapore Towards steadfast Outcomes (GUSTO) commencement cohort study. Int. J. Epidemiol. 43, 1401–1409 (2014).
Yap, J. et al. Harnessing exertion and molecular investigation to recognize the improvement of cardiovascular diseases successful Asia: a prospective cohort survey (SingHEART). BMC Cardiovasc. Disord. 19, 259 (2019).
Van der Auwera G. A. & O'Connor, B. D. Genomics successful the Cloud: Using Docker, GATK, and WDL successful Terra 1st edn (O’Reilly Media, 2020).
Poplin, R. et al. Scaling close familial variant find to tens of thousands of samples. Preprint astatine bioRxiv https://doi.org/10.1101/201178 (2018).
McLaren, W. et al. The Ensembl Variant Effect Predictor. Genome Biol. 17, 122 (2016).
Landrum, M. J. et al. ClinVar: improving entree to variant interpretations and supporting evidence. Nucleic Acids Res. 46, D1062–D1067 (2018).
Code of Practice for Key Office Holders Under the Healthcare Services Act (Singapore Ministry of Health, 2019).
Doyle, D. L. et al. 2013 reappraisal and update of the familial counseling signifier based competencies by a task unit of the accreditation assembly for familial counseling. J. Genet. Couns. 25, 868–879 (2016).
Christenhusz, G. M., Devriendt, K. & Dierickx, K. To archer oregon not to tell? A systematic reappraisal of ethical reflections connected incidental findings arising successful genetics contexts. Eur. J. Hum. Genet. 21, 248–255 (2013).
Green, R. C. et al. ACMG recommendations for reporting of incidental findings successful objective exome and genome sequencing. Genet. Med. 15, 565–574 (2013).
eMERGE Clinical Annotation Working Group. Frequency of genomic secondary findings among 21,915 eMERGE web participants. Genet. Med. 22, 1470–1477 (2020).
Kuo, C. W. et al. Frequency and spectrum of actionable pathogenic secondary findings successful Taiwanese exomes. Mol. Genet. Genomic Med. 8, e1455 (2020).
Chen, W. et al. Secondary findings successful 421 full exome-sequenced Chinese children. Hum. Genomics 12, 42 (2018).
Van Hout, C. V. et al. Exome sequencing and characterization of 49,960 individuals successful the UK Biobank. Nature 586, 749–756 (2020).
Cohen, J. T., Goodell, S. & Neumann, P. J. The outgo savings and cost-effectiveness of objective preventive care. In Synthesis Project (Robert Wood Johnson Foundation, 2009).
Hatz, M. H., Schremser, K. & Rogowski, W. H. Is individualized medicine much cost-effective? A systematic review. Pharmacoeconomics 32, 443–455 (2014).
Kasztura, M., Richard, A., Bempong, N. E., Loncar, D. & Flahault, A. Cost-effectiveness of precision medicine: a scoping review. Int. J. Public Health 64, 1261–1271 (2019).
Acknowledgements
We convey each investigators, unit members and survey participants of the contributing cohorts and studies: (1) the HELIOS survey astatine the Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore; (2) the GUSTO survey jointly hosted by the National University Hospital, KK Women’s and Children’s Hospital, the National University of Singapore and the Singapore Institute for Clinical Sciences, the Agency for Science Technology and Research (A*STAR); (3) the SEED cohort astatine the Singapore Eye Research Institute; (4) the MEC, National University of Singapore; (5) the PRISM cohort; and (6) the TTSH Personalised Medicine Normal Controls cohort. We besides convey the National Supercomputing Centre, Singapore (https://www.ncss.sg) for computation resources. The SG10K_Health task is funded by the Industry Alignment Fund (Pre-Positioning) (IAF-PP, H17/01/a0/007); the task made usage of participating survey cohorts supported by the pursuing backing sources: (1) the HELIOS survey by grants from a Strategic Initiative astatine Lee Kong Chian School of Medicine, the Singapore MOH nether its Singapore Translational Research Investigator Award (NMRC/STaR/0028/2017) and the IAF-PP (H18/01/a0/016); (2) the GUSTO survey by the Singapore National Research Foundation nether its Translational and Clinical Research Flagship Program and administered by the Singapore MOH’s National Medical Research Council Singapore (NMRC/TCR/004-NUS/2008, NMRC/TCR/012-NUHS/2014) with further backing enactment disposable done the A*STAR and the IAF-PP (H17/01/a0/005); (3) the SEED survey by NMRC/CIRG/1417/2015, NMRC/CIRG/1488/2018 and NMRC/OFLCG/004/2018; (4) the MEC by idiosyncratic probe and objective idiosyncratic grant schemes from the Singapore National Medical Research Council (including MOH-000271-00) and the Singapore Biomedical Research Council, the Singapore MOH, the National University of Singapore and the Singapore National University Health System; (5) the PRISM cohort survey by NMRC/CG/M006/2017_NHCS, NMRC/STaR/0011/2012, NMRC/STaR/0026/2015, the Lee Foundation and the Tanoto Foundation; and (6) the TTSH cohort survey by NMRC/CG12AUG2017 and CGAug16M012. This probe is besides supported by the National Research Foundation Singapore nether its NPM programme Phase II backing (MOH-000588) and administered by the Singapore MOH’s National Medical Research Council.
Ethics declarations
Competing interests
The authors state nary competing interests.
Peer review
Peer reappraisal information
Nature Genetics acknowledgment Mark Caulfield and Philip Wilcox for their publication to the adjacent reappraisal of this work.
Additional information
Publisher’s note Springer Nature remains neutral with respect to jurisdictional claims successful published maps and organization affiliations.
Rights and permissions
Springer Nature oregon its licensor (e.g. a nine oregon different partner) holds exclusive rights to this nonfiction nether a publishing statement with the author(s) oregon different rightsholder(s); writer self-archiving of the accepted manuscript mentation of this nonfiction is solely governed by the presumption of specified publishing statement and applicable law.
About this article
Cite this article
Wong, E., Bertin, N., Hebrard, M. et al. The Singapore National Precision Medicine Strategy. Nat Genet (2023). https://doi.org/10.1038/s41588-022-01274-x
Received: 30 March 2022
Accepted: 30 November 2022
Published: 19 January 2023
DOI: https://doi.org/10.1038/s41588-022-01274-x
English (US)